Sectoral Asset Management’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Sectoral Asset Management’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-541,765	Closed	-$1.73M	–	127
2022 Q1	$1.73M	Sell	541,765 -1	-0%	-$3	0.31%	86
2021 Q4	$1.55M	Hold	541,766	–	–	0.23%	88
2021 Q3	$2.15M	Hold	541,766	–	–	0.18%	107
2021 Q2	$3.23M	Hold	541,766	–	–	0.26%	96
2021 Q1	$6.58M	Sell	541,766 -7,036	-1%	-$100K	0.5%	70
2020 Q4	$8.01M	Sell	548,802 -51,885	-9%	-$661K	0.56%	63
2020 Q3	$6.91M	Buy	+600,687	New	+$7.7M	0.59%	62

Sectoral Asset Management's CMPI Position: Q2 2022 in Review

Sectoral Asset Management sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2022, closing a stake of 541,765 shares — an estimated $1.73M sold.

Sectoral Asset Management first reported a position in CMPI in Q3 2020 and held it in 7 quarters. The position peaked at $8.01M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMPI as of Q2 2022.

Sectoral Asset Management reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Sectoral Asset Management sold 541,765 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $1.73M.
Sectoral Asset Management first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Sectoral Asset Management's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $8.01M in Q4 2020.
0 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Sectoral Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.